Taking Stock of Regulatory Variation  by Maurano, Matthew T. & Stamatoyannopoulos, John A.
Cell Systems
PreviewsTaking Stock of Regulatory VariationMatthew T. Maurano1,2 and John A. Stamatoyannopoulos3,4,*
1Institute for Systems Genetics, New York University Langone Medical Center, New York, NY 10016, USA
2Department of Pathology, New York University Langone Medical Center, New York, NY 10016, USA
3Department of Genome Sciences, University of Washington, Seattle, WA 98115, USA
4Division of Oncology, Department of Medicine, University of Washington, Seattle, WA 98115, USA
*Correspondence: jstam@u.washington.edu
http://dx.doi.org/10.1016/j.cels.2015.07.011
Three recent studies measure individual variation in regulatory DNA accessibility. What do they tell us about
the prospects of assessing variation in single cells and across populations?The human genome harbors millions of
regulatory regions—chiefly distal, non-
promoter elements—that are activated in
a cell-selective fashion to specify tran-
scription programs. Three recent studies
appearing in this issue of Cell Systems,
inNature, and inScienceprovide newper-
spectives on the variability of regulatory
DNA activation among populations of
primary human immune cells sampled
from multiple individuals (Qu et al., 2015,
this issue) or between single cells sampled
fromcultured humancell lines (Buenrostro
et al., 2015; Cusanovich et al., 2015). The
results offer insights into larger-scale
studies of regulatory variation at individual
and population levels. Here, we provide a
brief overview of this recent work and
assess the comprehensiveness and po-
tential intrinsic limitations of approaches
for single-cell analysis of regulatory DNA
accessibility.
The actuation of regulatory DNA is trig-
gered by occupancy of sequence-spe-
cific transcription factors over a 200 bp
region in place of a canonical nucleo-
some, resulting in local remodeling of
chromatin structure and the appearance
of DNase I hypersensitive sites (DHSs;
Gross and Garrard, 1988). In principle,
regulatory DNA accessibility varies deter-
ministically along three principal axes:
variation between types of cells from the
same individual (cell-type axis); variation
between cells of the same type sampled
from different individuals (genotype axis);
and variation between individual cells
within a population of a given cell type
(cell-state axis).
Of these, the cell-type axis has been
extensively characterized and evinces
themostmarked variability: the regulatory
landscape of a typical cell-type popula-
tion (sampled at the level of millions of18 Cell Systems 1, July 29, 2015 ª2015 Elsevcells) is demarcated by 150,000 DNase
I hypersensitive sites, of which the major-
ity are cell type- or lineage-selective. Typi-
cally, hundreds to thousands of elements
remain entirely unique to that cell type
even after comparison across hundreds
of diverse cell and tissue types (Thurman
et al., 2012).
The recent realization that common
disease- and trait-associated genetic
variation is concentrated in regulatory
DNA (Maurano et al., 2012a) has sparked
considerable interest in how regulatory
DNA activation varies between individuals
(the genotype axis). Analyses quantifying
transcription factorbindingsiteoccupancy
or DNase I hypersensitivity in immortalized
cell lines from related and unrelated indi-
viduals have disclosed heritable changes
in transcription factor activity (McDaniell
et al., 2010; Maurano et al., 2012b).
Differences in regulatory DNA acces-
sibility between individuals have been
reported to affect 2%–10% of elements
(depending on the study). However,
these numbers should be interpreted
cautiously, since the power to detect vari-
ability in regulatory DNA activation within
an individual depends on two related
parameters: (1) thequality (signal-to-noise
ratio and replicate concordance) of indi-
vidual datasets, and (2) the depth to which
a given dataset has been sequenced. Po-
wer to analyze inter-individual differences
also depends strongly on sample size,
but traditional chromatin assays such as
DNase-seq or ChIP-seq are technically
demanding and consumptive of sample.
Although nucleases provide the gold stan-
dard for quantifying DNA accessibility,
other DNA-modifying proteins can be
used for this purpose (Kelly et al., 2012).
Tn5 transposases loaded with Illumina
sequencing adapters are now widelyier Inc.used to generate shotgun genomic li-
braries (Adey et al., 2010) and have
recently been cleverly adapted to probe
DNA accessibility in an approach known
as ATAC-seq (Buenrostro et al., 2013).
In this issue, Qu et al. (2015) describe
the application of ATAC-seq to probe
DNA accessibility in resting and stimu-
lated total CD4+ T cells from 12 unrelated
individuals and analyze both genetic and
non-genetic contributions to individual
variation in chromatin structure. The au-
thors report that 7.2% of transposase-
accessible sites showed reproducible
variation across individuals, consistent
with ChIP-seq and DNase-seq studies
in immortalized cells. The majority of this
variability (64%) could be linked to nearby
detected polymorphisms; however, this
fraction is considerably higher than
reported by studies that quantitatively
analyzed the relationship between geno-
type and accessibility (Degner et al.,
2012; Maurano et al., 2012b).
The authors also explored the gender
axis, revealing that while an important
fraction of individual variation can be
correlated with gender, the majority ap-
pears to be individual-specific. Intrigu-
ingly, prior work suggests that some of
these differences may represent epige-
netic memory of past environmental
stimuli (Ostuni et al., 2013). Indeed, Qu
et al. describe individual variability in
accessibility in response to T cell acti-
vation with phorbol myristate acetate
(PMA) and ionomycin.
These are tantalizing findings that
expand on prior studies, particularly in
the use of primary versus immortalized
cells, and in the novel inclusion of immu-
nostimuli, which should be particularly
relevant for autoimmune disease. How-
ever, the small sample size (8 males and
Table 1. Approaches for Profiling Variability in Regulatory DNA Accessibility
Criterion Single Cell Homogenous Population (50,000 cells) Mixed Population (10M cells)
Scalability 100’s of cells 10’s–100’s of samples (in plate format) 10’s of samples
Elements profiled <500 >100,000 >100,000
Sensitivity 0.2%–20% 80%–100% 80%–100%
Dynamic range 0–2 (nearly binary) >2 logs >2 logs
Sample input requirements Individually manipulable
suspension cells
Majority of defined pure cell populations
in human body without expansion
Primary cells and tissues available
in quantity or expandable ex vivo
Cell handling and library
construction
Specialized microfluidics
or barcoding
Optimized techniques Standard techniques
Library complexity Low
(< 100,000 reads)
Good with optimization
(20–200M reads)
Highly complex
(> 200M reads)
Analysis Requires reference regulome
(no de novo detection)
De novo regulome mapping De novo regulome mapping
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should be regarded as tentative, as
should the number of individually variable
accessible sites (range of peaks detected
per sample = 6,110–44,994; median =
19,463). Clearly, the approach of Qu
et al. can be readily expanded to clarify
these issues using larger, more balanced
cohorts.
In contrast to the cell type and individ-
ual axes, cell-to-cell variation in the acti-
vation state of regulatory DNA remains
largely unexplored. TF gene expression
has long been known to exhibit stochastic
variation at the cellular level (Eldar and
Elowitz, 2010), and transcription factor
binding is inherently dynamic (Gebhardt
et al., 2013; Voss and Hager, 2014). This
stochasticity has been invoked to explain
complex behaviors such as differentiating
hematopoietic cells (Graf and Enver,
2009) and cellular reprogramming (Buga-
nim et al., 2012). Transient expression of
signaling molecules such as transcription
factors (Davis et al., 1987) or oncogenic
kinases (Iliopoulos et al., 2009) can in
turn trigger mitotically heritable alter-
ations in cellular state. Once considered
biological noise, stochastic variation in
the transcriptional states of genes encod-
ing regulatory factors may thus underpin
key aspects of cellular differentiation,
signaling, and aging.
Recently, two groups applied advances
in microfluidic manipulation or combina-
torial DNA barcoding construction to pro-
file regulatory DNA accessibility in indi-
vidual cells (Buenrostro et al., 2015;
Cusanovich et al., 2015). Similar ap-
proaches have also enabled the applica-
tion of genomic assays, such as RNA-
seq, to study hundreds to thousands ofindividual cells (Table 1) (Klein et al.,
2015; Macosko et al., 2015).
Buenrostro et al. reprogrammed a mi-
crofluidics chip to perform ATAC-seq on
dozens to hundreds of individual cells
sampled from several proliferating cell
lines for which extensive orthogonal data
had been generated by the ENCODE
project. Cusanovich et al. also collected
single-cell ATAC-seq data, but using a
different approach that adapted a combi-
natorial indexing scheme originally devel-
oped for haplotype-resolved sequencing:
by first labeling a small population of
nuclei with one sequencing barcode and
then shuffling the nuclei into a second
set of wells with a second barcode, the
authors generated ATAC-seq libraries
wherein a unique combination of two
barcodes linked individual sequence
reads to individual cell nuclei. In both
studies, similar to results from single-cell
RNA-seq (Tang et al., 2009), aggregation
of single-cell-level data approximated
results collected from much larger cell
populations.
However, unlike RNA-seq, wherein
each sequencing read directly samples
an RNA molecule itself, each sequencing
read from chromatin studies records a
single event (enzymatic cleavage) that
indirectly reflects local chromatin state.
Thus individual sequence reads are
largely uninformative; it is the accumula-
tion of multiple reads in close proximity
that enables reliable definition of the chro-
matin state. But because regulatory sites
are punctate elements and only present
in two copies in normal human genomes,
quantifying chromatin accessibility is
several orders of magnitude more chal-
lenging than single-cell RNA profiling.Cell SysteBoth single-cell ATAC-seq studies
attempt to surmount the challenge of
measuring accessibility at elements
within individual cells by using ensemble
data from hundreds to millions of cells.
Cusanovich et al. define detection of
regulatory DNA activation as the mapping
of a single sequencing read within
an ENCODE-annotated high-confidence
DNase I hypersensitive site derived from
a sample comprising millions of cells
of that cell type (Thurman et al., 2012).
Similarly, Buenrostro et al. map single-
cell data to a fixed number of peaks
(50,000) derived from averaging all cells
together.
How comprehensive are the data?
Here, comparison with widely used
ENCODE data is revealing. In a standard
ENCODE cell type investigated by both
single-cell studies, GM12878, an average
of only 1,910/117,915 DNase I hypersen-
sitive sites (1.6%) harbored one or more
sequencing reads in each of the 480 cells
reported by Buenrostro et al. (Figure 1A).
Cusanovich et al., report an even lower
Figure (0.2% of DHSs). However, even
in the former study, only 0.9% of
ENCODE-annotated DNase I hypersensi-
tive sites harbored more than one
sequencing read, the minimum possible
threshold for independent detection of
an individual regulatory feature. The data
are equally sparse across cells, with the
average ENCODE DNase I hypersensitive
sites overlapped by one or more mapping
reads in only 6/480 cells (1.3%). Impor-
tantly, these low proportions cannot be
remedied by deeper sequencing, since
libraries created from single cells exhibit
low complexity and were sequenced to
completion in both studies.ms 1, July 29, 2015 ª2015 Elsevier Inc. 19
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Figure 1. Technical Characteristics of Single-Cell ATAC-Seq Data
(A) Single-cell ATAC-seq (scATAC-seq) signal in 480 GM12878 lymphoblastoid cells at 2,000 randomly sampled DNase I hypersensitive sites (Buenrostro et al.,
2015); sites and cells are sorted by total aggregate reads.
(B and C) proportion of reference DNase I hypersensitive sites (1% FDR) overlapping one or more (1+) single-cell ATAC-seq (scATAC-seq) reads (Thurman et al.,
2012) broken down by (B) site strength; and (C) location relative to genes.
(D) Comparison of single-cell read distributions at reference DNase I hypersensitive sites and control set of sites from abdominal skin fibroblasts not accessible in
GM12878.
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ual regulatory regions varies by more
than two orders of magnitude (Thurman
et al., 2012), one would expect a priori
that incomplete sampling would lead
to overrepresention of the most highly
accessible elements such as promoters,
which is indeed the case (Figure 1B and
1C). Because the lack of information for
the vast majority of regulatory regions
combined with biased representation
toward more highly accessible elements
renders the single-cell data opaque to
analysis by itself, only the position of indi-
vidual cells along the cell-type axis can be
reliably resolved by exploiting population
reference regulomes. However, it is un-20 Cell Systems 1, July 29, 2015 ª2015 Elsevknown howmuch variability between indi-
vidual cells this overlooks.
Are the above limitations of single-cell
assays purely technical or symptomatic
of more fundamental limits? One such
limit is the vast size of the human genome,
only 1%–2% of which is accessible in a
given cell type. While population-aver-
aged accessibility may vary quantitatively
over multiple orders of magnitude to
reveal clear hypersensitive sites, single-
cell accessibility is necessarily nearly
binary, resulting in a measurement of
zero, one, or two cleavage (transposon
insertion) events per site (Figure 1D).
Thus, while two reads at a site in an indi-
vidual cell might provide strong evidenceier Inc.that that particular site is accessible, a
lack of reads can signify either true inac-
cessibility or undersampling in almost
equal measure (Figure 1D), meaning that
inaccessible sites in an individual cell are
largely indistinguishable from missing
data. Furthermore, this does not take
into consideration the additional chal-
lenge imposed by differences between
different regulatory alleles within the
same nucleus; for example, two reads
mapping within a reference site that lacks
genetic variation cannot be distinguished
from single reads mapping separately to
individual alleles.
Collectively, the studies of Qu et al.,
Buenrostro et al., and Cusanovich et al.
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Previewsprovide evidence that profiling of vari-
ability in chromatin state is rapidly extend-
ing its reach both broadly across individ-
uals and deeply into smaller amounts of
primary tissues (Table 1). While measure-
ment of sequence variation at both the
individual and population levels is a
necessary prerequisite for unraveling ge-
netic contributions to diseases and traits,
all genetic variation is ultimately inter-
preted in a cellular epigenetic context.
The expanded application of chromatin
profiling across cell-type, genetic, and
cellular axes will surely offer novel insight
into the precise molecular characteriza-
tion of cellular diversity and its relation-
ship to human traits and diseases.
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Genetic tools to engineer a prominent member of the human gut microbiome represent initial steps toward
cell-based diagnostics and therapeutics.Obesity, diabetes, colon cancer, and in-
flammatory bowel disease have all been
correlated with changes in the composi-
tion of the human gut microbiome (Cho
and Blaser, 2012), but understanding,
diagnosing, and therapeutically treating
gut dysbioses will require more sophisti-
cated tools than what we currently
possess. In this issue, Mimee et al.
(Mimee et al., 2015) develop a syntheticbiology toolbox for engineering a non-
model, prominent member of the human
gut microbiome, Bacteroides thetaiotao-
micron, to accurately detect and pre-
cisely respond to gut-localized signals.
This work provides a platform for engi-
neering this important bacterium to
perform useful tasks, and an example
of how synthetic biology tools devel-
oped in model organisms can be adapt-ed for non-model, biologically relevant
organisms.
Scientists studying the human micro-
biome have lately shifted their focus from
describing its correlations with disease to
understanding the underlying causes of
these correlations at the molecular level.
Elegant studies using microbiome trans-
plantation in mice provide strong support
for the hypothesis that changes in thems 1, July 29, 2015 ª2015 Elsevier Inc. 21
